Rapid Micro Biosystems: Record Revenue Growth and Gross Margin Expansion in Q4 2024
Saturday, Mar 1, 2025 2:17 am ET
Rapid Micro Biosystems (RPID) reported strong financial results for the fourth quarter and full year 2024, demonstrating meaningful traction in its financial transformation. The company achieved record quarterly revenue of $8.2 million, representing a 30% year-over-year increase, and full-year revenue of $28.1 million, up 25% compared to 2023. Notably, RPID's gross margin expanded dramatically to 12% in Q4 2024, a 15-point improvement from the same period in 2023, indicating increasing operational leverage.